BRIEF published on 09/02/2026 at 12:35, 15 days 14 hours ago Immunic to Host Virtual R&D Day on Multiple Sclerosis Biotechnology Immunic Vidofludimus Calcium Relapsing MS R&D Event
PRESS RELEASE published on 09/02/2026 at 12:30, 15 days 14 hours ago Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 Immunic, Inc. to host a virtual R&D day on relapsing multiple sclerosis on September 9, 2026, discussing its Phase 3 trial asset, vidofludimus calcium, to address neurologic diseases Immunic Inc. Phase 3 Trial Vidofludimus Calcium Relapsing Multiple Sclerosis Virtual R&D Day
BRIEF published on 09/01/2026 at 12:35, 16 days 14 hours ago Immunic Appoints Chitrang Davé as Chief Data and Digital Officer Multiple Sclerosis Immunic Vidofludimus Calcium Chitrang Davé Data And Digital
PRESS RELEASE published on 09/01/2026 at 12:30, 16 days 14 hours ago Immunic Appoints Chitrang Davé as Chief Data and Digital Officer Immunic appoints Chitrang Davé as Chief Data and Digital Officer, reinforcing commitment to building a robust data ecosystem for potential NDA submission and commercialization Chief Data Officer Immunic Digital Officer NDA Submission Chitrang Davé
BRIEF published on 08/11/2026 at 12:35, 1 month 6 days ago Immunic, Inc. Reports Q2 2026 Financial Results and Updates Vidofludimus Calcium Leadership Appointments Multiple Sclerosis Trials Biotech Investments Immunic Financials
PRESS RELEASE published on 08/11/2026 at 12:30, 1 month 6 days ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update Immunic, Inc. reports Q2 2026 financial results and corporate update, with leadership team expansions and Phase 3 trials progress for vidofludimus calcium in MS Financial Results Corporate Update Immunic Inc. Vidofludimus Calcium Q2 2026
BRIEF published on 08/10/2026 at 22:10, 1 month 7 days ago Elena Ridloff Joins Immunic's Board as Strategic Director Vidofludimus Calcium Immunic Board Elena Ridloff Biotechnology Leadership Phase 3 ENSURE
PRESS RELEASE published on 08/10/2026 at 22:05, 1 month 7 days ago Immunic Appoints Elena Ridloff to Board of Directors Immunic appoints Elena Ridloff, a financial and capital markets expert, to its Board of Directors, enhancing leadership as the company approaches pivotal phase 3 ENSURE Readout for Multiple Sclerosis treatments Board Of Directors Immunic Elena Ridloff MS Treatments ENSURE Readout
BRIEF published on 07/09/2026 at 12:35, 2 months 8 days ago Immunic Announces Participation in July Investor Conferences Biotechnology Investor Conferences Immunic Inc. Oral Therapies Neurologic Diseases
PRESS RELEASE published on 07/09/2026 at 12:30, 2 months 8 days ago Immunic to Participate in Investor Conferences in July Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in July, presenting at Leerink Partners Therapeutics Forum and B. Riley Securities Mind, Muscle & Vision Summit in Boston Investor Conferences Immunic Inc B. Riley Securities Neurologic Diseases Leerink Partners
Published on 09/18/2026 at 00:55, 2 hours 1 minute ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 2 hours 31 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 4 hours 41 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 4 hours 41 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 4 hours 51 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 19:00, 7 hours 56 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 7 hours 57 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 8 hours 31 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 8 hours 46 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 9 hours 10 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 9 hours 16 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 9 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 19 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
